Retrospective Multicenter Comparative Study of the Efficacy and Safety Between R-DHAC and R-DHAOx in Diffuse Large B-cell Lymphoma or Transformed Follicular or Marginal Zone B Lymphoma into Aggressive Lymphoma, As a Second-line Treatment